Comment from EveryLife Foundation for Rare Diseases

Summary: The EveryLife Foundation for Rare Diseases supports the FDA's draft guidance on the Plausible Mechanism Framework, viewing it as a significant step toward predictable and consistent regulatory pathways for ultra-rare diseases. They request specific clarifications regarding eligible populations, therapeutic modalities, natural history data standards, and manufacturing requirements to ensure the framework is broadly applicable and effective.